Objective-To search for possible serum factors (immunochemical abnormalities) that reflect HLA-B27 associated inflammatory process with the proliferative endarteritis, which is an important cause of severe bradycardia and aortic valve regurgitation.
malities were common among patients of all groups; 30 (41%) had antinuclear antibodies or rheumatoid factor or both.
Conclusion-The platelet aggregating activity found in patients with HLA-B27 and associated rheumatic and cardiac conditions may reflect serum factors that increase the stickiness of platelets and increase their adhesion to the vessel wall. This suggests a link via release of platelet derived growth factor(s) with the characteristic histopathological feature of proliferative endarteritis. Immunochemical abnormalities were common in serum from all men with pacemakers.
The HLA-B27 allele is associated with a predisposition to seronegative spondarthritides and impairment of the cardiac conduction system,''3 the aortic and mitral valves,47 and the myocardium.89 The most common and clinically important cardiac disorders are complete heart block and aortic valve regurgitation. A substantial proportion (15-20%) of men with pacemakers3 10'1 (but not women '2) and of white patients with aortic valve regurgitation have the HLA-B27 allele."" The histopathological features of the disease process include perivascular infiltration of inflammatory cells around small vessels such as the vasa vasorum of the proximal aorta and around vessels in the interventricular septum and vessels adjacent to the affected joints. The lumens of these vessels are obliterated by endothelial and fibromuscular proliferation (endarteritis obliterans).' 5 16 In the present study we looked for immunochemical factors in the serum that could be linked to the proliferative vascular disease in HLA-B27 positive patients.
Patients and methods

PATIENTS
We studied men with pacemakers who had been examined for HLA-B27 associated rheumatic disorders.3 1011 When the history was taken we noted any signs or symptoms that might have been linked with HLA-B27 such as acute anterior uveitis, low back pain, arthritis or arthralgia, psoriasis, inflammatory bowel disease, and urogenital infection or discharge. The sacroiliac joints in all patients in the three groups had been x rayed, and patients with confirmed sacroiliitis were also examined for spondylitis. We used the 1966 New York criteria for ankylosing spondylitis and sacroiliitis was diagnosed only when we found radiographic changes of grade 2 (definite changes) to Our results were unremarkable and consistent with other studies of patients with ankylosing spondylitis. There are, however, three observations of interest. First, we found platelet aggregating activity in 57% of the patients with HLA-B27 associated disorders (group 1) but not in the other groups. This is an original observation. We used platelet aggregating activity to search for circulating immune complexes. Norberg found platelet aggregating activity in 36 out of 171 patients with rheumatoid arthritis.28 This activity was probably due to the presence of circulating immune complexes.' In our study, however, only three patients with the rheumatic and cardiac syndromes had positive Clq-binding or conglutinin tests, suggesting circulating immune complexes, and two of them had no platelet aggregation. Furthermore, platelet aggregating activity was not associated with an increase in acute phase reactants, which were normal in eight of the 13 patients with platelet aggregating activity. Neither was there a relation with increased immunoglobulin concentrations, which were found in only two ofthe 24 patients in this group.
Our observations need to be confirmed by other in vitro and in vivo tests of platelet aggregation and the cause of this activity must be elucidated. In theory, the platelet aggregating activity could be related to serum factors that can increase the stickiness of platelets and facilitate their adhesion to the vessel wall.29 Platelet We found that immunochemical abnormalities were common in all groups. This accords with a recent report of antinuclear antibodies in 54% of 65 patients with atrioventricular block and in 47% of 45 patients with sick sinus syndrome, all of them with pacemakers. 32 We based the diagnosis of rheumatoid disease in patients with the HLA-B27 allele on the presence of one or more of the most typical clinical manifestations: radiographically verified sacroiliitis, Reiter's disease, and acute anterior uveitis. We grouped the HLA-B27 associated syndromes together because of (a) the considerable clinical overlap in individuals and within families; (b) the various disease manifestations or tissue disorders show separate association with HLA-B273"35; (c) the similarity of the heart manifestations in patients with different B27 associated rheumatic and ocular disorders, and the fact that in white men the combination of clinically significant bradycardia and pure aortic valve regurgitation is basically an HLA-B27 associated syndrome with 88% of the patients being HLA-B27 positive3"5; (d), and histopathological changes are similar in periarticular and non-articular tissues.516 None the less, the HLA-B27 allele is not a diagnostic criterion in the disorders listed above, and disease processes not associated with HLA-B27 may lead to similar clinical manifestations. All the patients in group 1 had the rheumatic and/or ocular manifestations associated with HLA-B27. Six of seven patients with rheumatoid factor in group 1 had radiographically confirmed sacroiliitis or spondylitis or both. The seventh patient had a titre 1/20. Furthermore, other criteria of rheumatoid arthritis were not found in these patients. We therefore firmly believe the rheumatoid factor was coincidental. Presumably the disease process associated with HLA-B27 was also the underlying cause of the cardiac disease in these patients. No other cause was found, and there was histopathological evidence to support this assumption in three patients. 7 We cannot regard the presence of cardiac disorders as evidence of a particularly severe inflammatory process in our patients because the severity of joint disease does not parallel the cardiac manifestations. 3 Furthermore, because up to 20% of patients with ankylosing spondylitis have either high degree atrioventricular block or aortic regurgitation,36 37 earlier studies of immunochemical serum factors must surely have included patients with these cardiac manifestations.
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